61-70 items (total 82)
Published At May 23, 2022
Discovery that Drug-Sensitive Strains Acquire Drug Resistance via Extracellular Vesicles Secreted by Treatment-Resistant Multiple Myeloma Cells¡ªElucidating One Mechanism by Which Drugs Lose Efficacy with Long-Term Use¡ª
Public Relations Office
Published At May 23, 2022
The June 2022 issue of *Jikken Igaku* (Experimental Medicine), titled "Tackling Disease from the Gut: Microbiome Drug Discovery," has been published. This special issue
Faculty of Pharmacy/Graduate School of Pharmaceutical Sciences
Published At April 21, 2022
Phase 1 Trial Results Published for Gut Microbiota Drug (VE303) Developed by Inventor Professor Kim Im-gi
Faculty of Pharmacy/Graduate School of Pharmaceutical Sciences
Published At March 09, 2022
Discovery That Gut Bacteria Enhance Defense Against Oxidative Stress¡ªHopes for Drug Discovery and Food Development Utilizing Reactive Sulfur-Producing Bacteria That Suppress Oxidative Stress
Public Relations Office
Published At February 15, 2022
Establishing Organoids for Personalized Medicine in Biliary Tract Cancer¡ªPresenting Future Prospects through an International Multi-center Collaborative Study
Public Relations Office
Published At November 15, 2021
Discovery that Prognosis of Immune Checkpoint Inhibitor Treatment Can Be Predicted by Combining Concomitant Medications and Neutrophil-to-Lymphocyte Ratio¡ªHopes for the Development of New Methods to Improve Efficacy¡ª
Public Relations Office
Published At October 05, 2021
Gut Microbiota-Derived Acetate Improves Hepatic Insulin Resistance and Suppresses Non-alcoholic Steatohepatitis (NASH) - Potential for Next-Generation NASH Therapies Targeting Gut Microbiota -
Public Relations Office
Published At September 27, 2021
Marine Dietary Fiber Alginic Acid Found to Suppress Metabolic Syndrome via Gut Microbiota¡ªHopes for Development of Preventive Measures by Improving the Gut Environment
Public Relations Office
Published At September 03, 2021
Development of a Novel Cyanide Antidote from Artificial Red Blood Cells: Expected to be Effective in Treating Cyanide Poisoning with its Rapid Action and Versatility
Public Relations Office
Published At July 16, 2021
Peripheral Blood Lymphocyte Count Found to Predict Immune-Related Adverse Events from Immune Checkpoint Inhibitors¡ªHopes for Early Detection and Management of "High-Risk Patients"¡ª
Public Relations Office